BlackRock Group’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$252M Buy
2,518,591
+169,584
+7% +$18.2M 0.12% 201
2016
Q3
$297M Buy
2,349,007
+6,223
+0.3% +$769K 0.15% 159
2016
Q2
$274M Buy
2,342,784
+704,066
+43% +$79.7M 0.14% 165
2016
Q1
$170M Buy
1,638,718
+150,882
+10% +$14.6M 0.09% 265
2015
Q4
$148M Buy
1,487,836
+106,938
+8% +$10.5M 0.08% 277
2015
Q3
$126M Buy
1,380,898
+32,431
+2% +$3.25M 0.07% 303
2015
Q2
$143M Sell
1,348,467
-316,183
-19% -$35M 0.08% 290
2015
Q1
$190M Sell
1,664,650
-25,944
-2% -$2.96M 0.1% 232
2014
Q4
$186M Sell
1,690,594
-143
-0% -$15.1K 0.1% 239
2014
Q3
$165M Buy
1,690,737
+18,924
+1% +$1.86M 0.1% 243
2014
Q2
$169M Buy
1,671,813
+91,007
+6% +$8.88M 0.1% 252
2014
Q1
$145M Sell
1,580,806
-16,343
-1% -$1.51M 0.09% 249
2013
Q4
$145M Sell
1,597,149
-30,651
-2% -$2.65M 0.09% 247
2013
Q3
$130M Buy
1,627,800
+102,953
+7% +$8.1M 0.09% 260
2013
Q2
$111M Buy
+1,524,847
New +$114M 0.08% 266

Other funds holding ZBH

BlackRock Group's ZBH Position: Q4 2016 in Review

BlackRock Group increased its Zimmer Biomet (ZBH) stake by 7.2% in Q4 2016, buying an estimated $18.2M and bringing the position to 2,518,591 shares worth $252M. The position accounts for 0.12% of the portfolio, ranked #201.

BlackRock Group first reported a position in ZBH in Q2 2013 and has held it in 15 quarters since. The position peaked at $297M in Q3 2016. 812 funds tracked by Wall St. Rank hold ZBH as of Q4 2016.

  • BlackRock Group held 2,518,591 shares of Zimmer Biomet worth $252M as of Q4 2016.
  • BlackRock Group bought 169,584 Zimmer Biomet shares in Q4 2016, an estimated $18.2M.
  • Zimmer Biomet made up 0.12% of BlackRock Group's portfolio in Q4 2016, its #201 holding.
  • BlackRock Group first reported a position in Zimmer Biomet in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Group's Zimmer Biomet position peaked at $297M in Q3 2016.
  • 812 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.